ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma

Katherine E. Hutchinson*, Douglas B. Johnson, Adam S. Johnson, Violeta Sanchez, Maria Kuba, Pengcheng Lu, Xi Chen, Mark C. Kelley, Qingguo Wang, Zhongming Zhao, Mark Kris, Michael F. Berger, Jeffrey A. Sosman, William Pao

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences